固体器官移植接受者和癌症中的免疫检查点阻断剂:INNOVATED队列队列

J Remon1, E Auclin2, L Zubiri3

  • 1Paris-Saclay University, Department of Cancer Medicine, Gustave Roussy, Villejuif.

ESMO open
|April 23, 2024
PubMed
概括

免疫检查点阻断剂 (ICB) 在患有晚期癌症的固体器官移植 (SOT) 接受者中显示可行性,在其他人失败时提供治疗选择. 仔细的多学科团队参与是至关重要的,因为潜在的异种移植拒绝风险.

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
520
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
68.2K
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
360
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K